Physicians Realty Trust (DOC) Trades at $14.86 After Triangle; Deere & Co Has 0.87 Sentiment

June 10, 2018 - By Ash

Deere & Company (NYSE:DE) Logo

Deere & Co (DE) investors sentiment decreased to 0.87 in Q1 2018. It’s down -0.16, from 1.03 in 2017Q4. The ratio dropped, as 372 institutional investors opened new or increased positions, while 426 cut down and sold positions in Deere & Co. The institutional investors in our database reported: 210.24 million shares, up from 209.89 million shares in 2017Q4. Also, the number of institutional investors holding Deere & Co in top ten positions decreased from 25 to 21 for a decrease of 4. Sold All: 62 Reduced: 364 Increased: 283 New Position: 89.

Physicians Realty Trust (DOC) formed triangle with $15.31 target or 3.00% above today’s $14.86 share price. Physicians Realty Trust (DOC) has $2.79B valuation. The stock increased 0.07% or $0.01 during the last trading session, reaching $14.86. About 1.96M shares traded or 27.56% up from the average. Physicians Realty Trust (NYSE:DOC) has declined 26.95% since June 10, 2017 and is downtrending. It has underperformed by 39.52% the S&P500. Some Historical DOC News: ; 04/05/2018 – PHYSICIANS REALTY 1Q NORMALIZED FFO/SHR 26C, EST. 27C; 04/05/2018 – Physicians Realty Trust 1Q Rev $105.2M; 04/05/2018 – PHYSICIANS REALTY 1Q REV. $105.2M, EST. $101.7M; 04/05/2018 – Physicians Realty Trust: 1Q Normalized FFO $49.0 Million, or 26c Per Share; 16/04/2018 Wheeler Real Estate Investment Trust, Inc. Announces Changes to its Board of Directors; 04/05/2018 – Physicians Realty Trust 1Q EPS 6c; 23/04/2018 – DJ Physicians Realty Trust, Inst Holders, 1Q 2018 (DOC); 04/05/2018 – Prudential Financial Inc. Exits Position in Physicians Realty; 04/05/2018 – PHYSICIANS REALTY TRUST QTRLY SAME-STORE CASH NET OPERATING INCOME GROWTH WAS 2.6% YEAR OVER YEAR

Investors sentiment increased to 1.13 in 2018 Q1. Its up 0.04, from 1.09 in 2017Q4. It increased, as 26 investors sold Physicians Realty Trust shares while 72 reduced holdings. 35 funds opened positions while 76 raised stakes. 164.93 million shares or 0.70% more from 163.78 million shares in 2017Q4 were reported. Vident Advisory Limited Liability Corporation holds 0.01% or 14,927 shares in its portfolio. Balyasny Asset Management Limited Liability Corp holds 1.05 million shares. Prudential Plc holds 0% of its portfolio in Physicians Realty Trust (NYSE:DOC) for 10,400 shares. Natixis L P has invested 0% in Physicians Realty Trust (NYSE:DOC). Indexiq Advisors Limited Liability Company holds 0.09% of its portfolio in Physicians Realty Trust (NYSE:DOC) for 175,047 shares. Seabridge Inv Advsr Lc has invested 0% in Physicians Realty Trust (NYSE:DOC). Prudential Financial invested in 0% or 17,810 shares. Voloridge Investment Mngmt Lc reported 85,939 shares. Pub Employees Retirement Association Of Colorado accumulated 24,883 shares. Dumont Blake Invest Advsrs Ltd Co reported 30,650 shares. Sandler Mgmt owns 23,500 shares. Asset Management holds 0.03% in Physicians Realty Trust (NYSE:DOC) or 12,439 shares. Segall Bryant & Hamill Ltd holds 0.11% or 300,574 shares in its portfolio. Moreover, Hightower Limited Liability Corp has 0% invested in Physicians Realty Trust (NYSE:DOC) for 29,823 shares. Alyeska Inv Grp Incorporated Limited Partnership holds 0.07% or 466,596 shares in its portfolio.

Among 18 analysts covering Physicians Realty Trust (NYSE:DOC), 14 have Buy rating, 0 Sell and 4 Hold. Therefore 78% are positive. Physicians Realty Trust has $25 highest and $16.0 lowest target. $18.44’s average target is 24.09% above currents $14.86 stock price. Physicians Realty Trust had 64 analyst reports since August 10, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Monday, September 11 with “Buy”. The rating was initiated by Morgan Stanley on Wednesday, December 9 with “Underweight”. The stock of Physicians Realty Trust (NYSE:DOC) earned “Buy” rating by KeyBanc Capital Markets on Monday, April 16. The rating was maintained by BMO Capital Markets on Monday, September 4 with “Buy”. The rating was maintained by Morgan Stanley with “Equal-Weight” on Tuesday, March 20. The stock has “Hold” rating by Jefferies on Monday, October 23. The firm earned “Hold” rating on Monday, August 21 by Jefferies. The rating was maintained by BMO Capital Markets on Tuesday, January 9 with “Buy”. Canaccord Genuity maintained the stock with “Buy” rating in Tuesday, August 11 report. BTIG Research initiated Physicians Realty Trust (NYSE:DOC) rating on Thursday, August 25. BTIG Research has “Buy” rating and $25 target.

Analysts await Physicians Realty Trust (NYSE:DOC) to report earnings on August, 2. They expect $0.28 EPS, up 16.67% or $0.04 from last year’s $0.24 per share. DOC’s profit will be $52.50M for 13.27 P/E if the $0.28 EPS becomes a reality. After $0.26 actual EPS reported by Physicians Realty Trust for the previous quarter, Wall Street now forecasts 7.69% EPS growth.

Marshfield Associates holds 7.63% of its portfolio in Deere & Company for 730,792 shares. Firefly Value Partners Lp owns 503,893 shares or 7.04% of their US portfolio. Moreover, Weybosset Research & Management Llc has 5.65% invested in the company for 60,534 shares. The Connecticut-based Tide Point Capital Management Lp has invested 5.51% in the stock. Birmingham Capital Management Co Inc Al, a Alabama-based fund reported 73,300 shares.

More notable recent Deere & Company (NYSE:DE) news were published by: Benzinga.com which released: “Three Industries Already Using Self-Driving Vehicles” on June 06, 2018, also Seekingalpha.com with their article: “What To Do With Deere Here” published on May 22, 2018, Investorplace.com published: “Deere & Company Stock Is Ready to Run!” on May 21, 2018. More interesting news about Deere & Company (NYSE:DE) were released by: Seekingalpha.com and their article: “Yes, Deere” published on May 22, 2018 as well as Nasdaq.com‘s news article titled: “Time to Get Greedy With Deere & Company Stock” with publication date: June 08, 2018.

Since January 1, 0001, it had 0 insider purchases, and 7 insider sales for $62.79 million activity.

Analysts await Deere & Company (NYSE:DE) to report earnings on August, 17. They expect $2.76 earnings per share, up 40.10% or $0.79 from last year’s $1.97 per share. DE’s profit will be $893.66M for 14.23 P/E if the $2.76 EPS becomes a reality. After $3.14 actual earnings per share reported by Deere & Company for the previous quarter, Wall Street now forecasts -12.10% negative EPS growth.

Ratings analysis reveals 44% of Deere’s analysts are positive. Out of 9 Wall Street analysts rating Deere, 4 give it “Buy”, 1 “Sell” rating, while 4 recommend “Hold”. The lowest target is $80.0 while the high is $126.0. The stock’s average target of $97.20 is -38.14% below today’s ($157.12) share price. DE was included in 9 notes of analysts from August 22, 2016. RBC Capital Markets maintained it with “Sector Perform” rating and $80.0 target in Monday, August 22 report. The stock of Deere & Company (NYSE:DE) earned “Sell” rating by Berenberg on Tuesday, January 24. Robert W. Baird upgraded it to “Outperform” rating and $100.0 target in Monday, October 31 report. The rating was initiated by Stifel Nicolaus with “Buy” on Tuesday, April 11. The company was upgraded on Monday, October 10 by Wells Fargo. The firm earned “Neutral” rating on Friday, November 25 by Longbow. The stock has “Neutral” rating by Piper Jaffray on Monday, November 28. The stock has “Buy” rating by Bank of America on Thursday, December 1. The rating was initiated by Deutsche Bank on Wednesday, September 7 with “Hold”.

Deere & Company (NYSE:DE) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>